Ypsomed Digital Health

Managing their own disease treatment is complex for many patients. Different treatment regimes, misinformation about the condition, and emotional distress with self-injection are only some of the factors that lead to poor therapy adherence and diminished treatment effectiveness.

We strongly believe that multifactorial support is needed to aid patients in managing their chronic condition.

We provide pharmaceutical companies with integrated digital solutions by combining connected injection devices with digital patient solutions. Ypsomed Digital Health helps facilitate therapy management for patients and generates business-changing insights for pharmaceutical companies.

Meet us at a live event

29
04

10th LSX World Congress 2024

Meet us in London to learn more about how real-world evidence and data can support clinical trials and improve patient outcomes while optimizing commercialization and pricing strategies for Pharma. Global Lead Digital Health at Ypsomed, Ventsislav Dobrev, will be taking part in the panel discussion ...

04
06

PDA Medical Devices & Connected Health Conference 2024

Meet us in Antwerp and explore patient perspectives on selfcare and self-injection and the implications for digital health solutions. Philippe Müller, Product Manager Digital Health at Ypsomed, will be presenting insights from Human Factors studies and perspectives from pharma representatives.

  • More
  • More
  • More

Seamlessly integrated connected injection devices with digital therapy management.

The value we offer

Connect

Drive outcomes and provide new insights to all stakeholders through establishing seamless technical and emotional connections. From device to digital, patient to caregiver and beyond, fueled by unbiased real-world data.

Engage

Effectively support adherence by increasing the patients' engagement. This is what our integrated digital solutions are designed for.

Empower

Take self-care to the next level. Equip the patients with the right tools and empower them to manage their therapy with ease.

The value we offer

Connect

Drive outcomes and provide new insights to all stakeholders through establishing seamless technical and emotional connections. From device to digital, patient to caregiver and beyond, fueled by unbiased real-world data.

Engage

Effectively support adherence by increasing the patients' engagement. This is what our integrated digital solutions are designed for.

Empower

Take self-care to the next level. Equip the patients with the right tools and empower them to manage their therapy with ease.

Our standards

Fulfils data
privacy

Follows cyber
security standards

Meets medical
device quality
system regulations

Ensures
interoperability

Our standards

Fulfils data privacy

Follows cyber
security standards

Meets medical device
quality system regulations

Ensures interoperability

Explore more

Explore more

Stay connected with us

Contact us to find out more on how our services can enhance your business. Start your Ypsomed journey today.

 

Your personal message

Note:
We only use the data you provide us with on this form for the above-mentioned purpose. We do not save the data on this web server. For more information on the collection and processing of your data, please refer to our Privacy Policy.

Latest Insights

Stay up to date on our recent news and publications here.

Digital health meets patient needs – the power of user testing

Are you looking for digital health solutions that are adopted by patients at the start of therapy and keeps them on the therapy for as long as it is necessary? Dive into the latest insights from Ypsomeds’ Human Factors studies on digital health solutions.

Ypsomed partners with S3 Connected Health to expand its digital health offering

Burgdorf – Ypsomed (SIX: YPSN) will expand its offering of digital health solutions together with S3 Connected Health in the future. S3 Connected Health, headquartered in Dublin, Ireland is a specialist digital health partner for life science companies.

Ypsomed partners with leading digital therapeutics innovator Sidekick Health to improve therapy outcomes

Burgdorf – Ypsomed (SIX: YPSN) and Sidekick Health today announced a collaboration to extend Ypsomed’s device and SmartServices offering by implementing a self-injection module in Sidekick’s proven digital therapeutics solution.